NCT00446641View on ClinicalTrials.gov

Overcome Biochemical Aspirin Resistance Through Cilostazol Combination

PHASE4CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Cerebral Infarction
Interventions
DRUG

Cilostazol

cilostazol 100mg twice a day for 4 weeks

DRUG

placebo

placebo 1 tablet twice a day matching for cilostazol

Trial Locations (4)

602-715

Jae-Kwan Cha, Busan

302-799

Eulji University Hospital, Daejeon

134-701

Kangdong Sacred Heart Hospital, Hallym University, Seoul

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

Asan Medical Center

OTHER